| ISIN | CH0023406587 |
|---|---|
| Valor Number | 2340658 |
| Bloomberg Global ID | MICHSWA SW |
| Fund Name | Migros Bank (CH) Fonds - SwissStock A |
| Fund Provider |
Migros Bank AG, Zurich
www.migrosbank.ch/kontakt |
| Fund Provider | Migros Bank AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of Mi-Fonds (CH) - Swiss Stock is principally to achieve long-term performance, which is consistent with the development of the Swiss equity market. |
| Peculiarities |
| Current Price * | 175.37 CHF | 20.11.2025 |
|---|---|---|
| Previous Price * | 174.94 CHF | 19.11.2025 |
| 52 Week High * | 179.21 CHF | 12.11.2025 |
| 52 Week Low * | 149.82 CHF | 09.04.2025 |
| NAV * | 175.37 CHF | 20.11.2025 |
| Issue Price * | 175.37 CHF | 20.11.2025 |
| Redemption Price * | 175.37 CHF | 20.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 521,845,646 | |
| Unit/Share Assets *** | 100,224,514 | |
| Trading Information SIX | ||
| YTD Performance | +10.20% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
|---|---|---|
| 1 month | -0.70% |
20.10.2025 - 20.11.2025
20.10.2025 20.11.2025 |
| 3 months | +0.72% |
20.08.2025 - 20.11.2025
20.08.2025 20.11.2025 |
| 6 months | +0.49% |
20.05.2025 - 20.11.2025
20.05.2025 20.11.2025 |
| 1 year | +10.77% |
20.11.2024 - 20.11.2025
20.11.2024 20.11.2025 |
| 2 years | +20.02% |
20.11.2023 - 20.11.2025
20.11.2023 20.11.2025 |
| 3 years | +19.01% |
21.11.2022 - 20.11.2025
21.11.2022 20.11.2025 |
| 5 years | +28.05% |
20.11.2020 - 20.11.2025
20.11.2020 20.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 11.69% | |
|---|---|---|
| Novartis AG Registered Shares | 11.10% | |
| Nestle SA | 11.06% | |
| UBS Group AG Registered Shares | 6.57% | |
| ABB Ltd | 5.28% | |
| Compagnie Financiere Richemont SA Class A | 5.27% | |
| Zurich Insurance Group AG | 5.20% | |
| Swiss Re AG | 2.58% | |
| Lonza Group Ltd | 2.56% | |
| Sika AG | 2.11% | |
| Last data update | 30.09.2025 | |
| TER | 0.90% |
|---|---|
| TER date | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.90% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |